Experimental models and treatment trials for cerebral infarction

Area of Science:

• Neurology
• Cerebrovascular Diseases
• Neuroscience

Background:

• Cerebral infarction (stroke) remains a leading cause of disability and death.
• Understanding the pathophysiology of ischemic brain injury is crucial for developing effective treatments.
• Delayed neuronal death and the concept of the ischemic penumbra are key areas of research.

Purpose of the Study:

• To outline recent progress in experimental and clinical studies of cerebral infarction.
• To review the development and application of animal models for studying stroke.
• To introduce current and experimental therapeutic strategies for cerebral ischemia and cerebrovascular dementia.

Main Methods:

• Review of experimental and clinical studies on cerebral infarction.
• Description of research on delayed neuronal death and ischemic penumbra.
• Introduction of a focal cerebral ischemia animal model and discussion of pharmaceutical agents and antiplatelet therapy.

Main Results:

• Significant progress has been made in understanding the pathophysiology of cerebral ischemia.
• Various pharmaceutical agents and practical treatment methods, including antiplatelet therapy, are now available.
• Animal models are instrumental in studying clinical pathophysiology and testing new treatments.

Conclusions:

• Elucidation of cerebral ischemia pathophysiology has led to new therapeutic options.
• Effective management strategies for cerebral infarction, including antiplatelet therapy, are established.
• Prevention and treatment of cerebrovascular dementia are also important considerations in stroke care.